FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1033-1035 April 1, 1999 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sarin, S. K. PubMed Citation

Most patients with portal hypertension in North America and Europe have cirrhosis. Of those with compensated cirrhosis (i.e., cirrhosis with no ascites, encephalopathy, or severe jaundice), 30 percent have esophageal varices, as compared with 60 percent of those with decompensated cirrhosis.¹ The risk of a first episode of bleeding from esophageal varices is higher among patients with cirrhosis who have severe liver dysfunction and those whose varices are large or have red signs — so-called varices on varices — identified endoscopically.² Patients with cirrhosis may also have bleeding due to portal hypertensive gastropathy, nonvariceal mucosal abnormalities seen on endoscopy. These . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (1999). Propranolol vs. Ligation to Prevent Variceal Bleeding. JWatch General 1999: 4-4 [Full Text]